Cargando…
Potential of the TRPM7 channel as a novel therapeutic target for pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is an intractable vascular disease characterized by a progressive increase in pulmonary vascular resistance caused by pulmonary vascular remodeling, which ultimately leads to right-sided heart failure. PAH remains incurable, despite the development of PAH-target...
Autores principales: | Hiraishi, Keizo, Kurahara, Lin Hai, Ishikawa, Kaori, Go, Tetsuhiko, Yokota, Naoya, Hu, Yaopeng, Fujita, Takayuki, Inoue, Ryuji, Hirano, Katsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Society of Smooth Muscle Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364263/ https://www.ncbi.nlm.nih.gov/pubmed/35944979 http://dx.doi.org/10.1540/jsmr.58.50 |
Ejemplares similares
-
An Arrhythmic Mutation E7K Facilitates TRPM4 Channel Activation via Enhanced PIP(2) Interaction
por: Hu, Yaopeng, et al.
Publicado: (2021) -
Substantial involvement of TRPM7 inhibition in the therapeutic effect of Ophiocordyceps sinensis on pulmonary hypertension
por: HIRAISHI, KEIZO, et al.
Publicado: (2021) -
The Role of TRPM4 in Cardiac Electrophysiology and Arrhythmogenesis
por: Hu, Yaopeng, et al.
Publicado: (2023) -
Significant contribution of TRPC6 channel-mediated Ca(2+) influx to
the pathogenesis of Crohn's disease fibrotic stenosis
por: Kurahara, Lin Hai, et al.
Publicado: (2016) -
Theoretical Investigation of the Mechanism by which A Gain-of-Function Mutation of the TRPM4 Channel Causes Conduction Block
por: Hu, Yaopeng, et al.
Publicado: (2021)